St. Louis-based Stereotaxis gets FDA nod for robotic heart device central to growth strategy

​The St. Louis surgical instrument maker has secured federal approval for a robotically-navigated device that aims to expand access to heart rhythm treatments for patients with complex conditions. 

Read More from Bizjournals.com Feed (2025-02-17 17:26:56)

Leave a Reply

Discover more from ZoomHoot - The Important Information You Need

Subscribe now to keep reading and get access to the full archive.

Continue reading